These 4 Biotech Penny Stocks Are Buys, According to Analysts
Four biotech penny stocks with upside to analyst price targets ranging from 42% to 291%.
Alex Clarke
5 Buy-Rated Stocks Priced Under $10 Offering Solid Alpha Potential
or these five stocks – which include a smaller cap mining company and a small-cap biotech play focused on developing specialty products for underserved patient populations read more!
This Recent Biotech IPO Has The Right Story At The Right Time – And The Right Pattern
The author of today’s article notes that high-profile IPOs typically follow a pattern – and given this pattern, he is bullish on “a biotech stock that went public just under a month ago with a story that perfectly fits the times, and whose stock has followed exactly that pattern.”
Insights On Genomics, Electric Vehicles, Blockchain And More From The Top Stock Picker Of 2020
2020 Top Stock Picker shares insights on the outlook for genomics, electric vehicles, blockchain technology and more.
Small- And Mid-Cap Biotech Picks For 2021
Small- And Mid-Cap Biotech Picks For 2021 and holdovers from 2020.
How To Capitalize On What Could Be “The Best Decade, Ever, For The Stock Market”
Now, as 2021 begins, the author of today’s article believes that the “next decade could easily be the best decade, ever, for the stock market as post-war euphoria and easy money policy couple with multiple hypergrowth technological breakthroughs to rapidly unlock tremendous and widespread economic value.”
Why Individual Stock Selection Will Be Key For Biotech Investors In 2021 – And RBC’s 15 Top Ideas
When it comes to biotech investing in 2021, healthcare stock analysts at RBC advised in a recent report that “Many pandemic-related influences are setting up the sector for outperformance but several factors could still work against the group, making individual stock selection a key priority…”
4 Biotech Penny Stocks To Watch Right Now – Including A Truly Psychedelic Stock
“Since we know small-cap stocks are hot and biotech stocks are as well, it might make sense to follow some smaller biotech penny stocks this month,”
1 Buy And 1 Sell To Prepare Your Portfolio For The Precision Medicine Mega Trend
One-size-fits-all drugs are giving way to precision medicine, which the author of today’s article expects will come to dominate the health care marketplace in the next three to five years.
Promising Test Results For Its Cancer Drugs Just Launched This Small Biotech To A Record High
On Monday, the small biotech stock highlighted in today’s article hit a record high, skyrocketing 95.1%. The catalyst?